The Canadian Institute > Pharma Patents

9th Annual Forum on

Pharma Patents

Safeguard Your Patents and Protect Your Revenue Stream by Strengthening Your Pharma Patent and Biotech Strategies

Thursday, November 04 to Friday, November 05, 2010
InterContinental Toronto Yorkville, Toronto, Ontario, Canada

SPEAKER FACULTY

Co-Chairs:

Dr. John Norman, PhD
Gowlings LLP

Jamie Mills
Partner, Borden Ladner Gervais LLP

Federal Court Judges:

The Honourable Justice Johanne Gauthier
Federal Court Trial Division

The Honourable Justice Roger T. Hughes
Federal Court Trial Division

Speakers:

David Aitken
Partner, Osler, Hoskin & Harcourt LLP

Dr. Gregory Bell, Ph.D.
Vice President, Charles River Associates

Anthony G. Creber
Partner, Gowlings LLP

Wayne Critchley
Senior Associate, Global Public Affairs’
Health & Life Sciences Practice
Former Executive Director, PMPRB

Mark Edward Davis
Partner, Heenan Blaikie LLP

Douglas Deeth
Founding Partner
Deeth Williams Wall LLP

Ronald E. Dimock
Partner, Dimock Stratton LLP

Brian R. Dorn, Ph.D
Attorney, Merchant & Gould, P.C. (U.S.)

Gunars A. Gaikis
Partner, Smart & Biggar/ Fetherstonhaugh

Steven Garland
Partner, Smart & Biggar/ Fetherstonhaugh

Tim Gilbert
Partner, Gilbert's LLP

Caroline Jacques
Senior Counsel Canada
International Legal Operations, Abbott

David K. Lee
Director, Office of Legislative and Regulatory
Modernization
Policy, Planning and International Affairs
Directorate (PPIAD)
Health Products and Food Branch,
Health Canada

Steven Mason
Partner, McCarthy Tétrault LLP

Eileen McMahon
Partner, Torys LLP

Beverley Moore
Borden Ladner Gervais LLP

Barbara Murchie
Partner, Bennett Jones LLP

Judith Robinson
Partner, Ogilvy Renault LLP

Rasmus Rojkjaer
Vice President, Head of Global Biologics R&D

Dr. John R. Rudolph
General Counsel & Corporate Secretary
Eli Lilly Canada, Inc.

Dr. Philip Schwab, Ph.D.
Vice President, Industry Relations
BlOTECanada

Workshop Leader:

Noel Courage
Partner, Bereskin & Parr LLP